--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About AGIO20260220C30
Biological Technology
Agios Pharmaceuticals, Inc., was incorporated in Delaware on August 7, 2007. The company is a biopharmaceutical company dedicated to transforming patients' lives through leadership in cell metabolism, with the goal of creating differentiated medicines for rare diseases, with a focus on classical hematology.
